Headache News and Research

Latest Headache News and Research

Handheld BrainScope device detects brain damage immediately after concussion

Researchers at NYU School of Medicine have developed a handheld device that can detect subtle brain damage immediately after concussion.

7 Aug 2007

18 to 25 percent of women suffer from migraines

For every man with a migraine, three women are struck by the severe headaches that often come with nausea, sensitivity to light and sound, and aura.

6 Aug 2007

Be aware! whispering stroke all too common

Scientists in the U.S. say some people experience subtle symptoms which are suggestive of a stroke without an actual stroke being diagnosed.

6 Aug 2007

Headaches of computerized medicine

Clinical information technology systems especially those known in the health care industry as computerized provider order entry (CPOE) systems promise to improve health outcomes, reduce medical errors and increase cost efficiency, but hospitals adopting them must plan for immense workflow issues and a host of other unanticipated consequences that come with them or face potentially crippling problems.

3 Aug 2007

Efalizumab effective in treatment of heavy psoriasis

A meta-analysis of four randomized Phase III placebo-controlled trials confirms that the injectable drug Efalizumab, a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that lead to the development of psoriasis, had an acceptable safety and efficacy profile in the treatment of psoriasis in heavy patients, researchers at Mount Sinai School of Medicine announced today.

3 Aug 2007

First confirmed human case of West Nile virus in Pennsylvania

State Health Secretary Dr. Calvin B. Johnson has reported this year's first confirmed human case of West Nile virus in Pennsylvania. The individual, a 56-year-old Clearfield County man, is recovering and has been discharged from the hospital.

3 Aug 2007

Chinese ginger latest food scare

In yet another food scare consumers have been warned about ginger imported from China which contains a toxic chemical.

1 Aug 2007

New oral contraceptive means 365 period free days a year

Women in the United States can now access the first low-dose combination contraceptive pill which stops their periods.

31 Jul 2007

IDM Pharma plans to amend NDA for Mifamurtide (L-MTP-PE) for the treatment of osteosarcoma

IDM Pharma, Inc. has announced that it has recently met with the U.S. Food and Drug Administration (FDA) and informed the FDA that the Company intends to take immediate action to supplement the data in its current New Drug Application (NDA) for mifamurtide (L-MTP-PE), formerly known as Junovan, which is being reviewed for the treatment of children and adolescents with non-metastatic osteosarcoma.

23 Jul 2007

NDA for Lubiprostone to treat irritable bowel syndrome with constipation

Sucampo Pharmaceuticals, Inc., has announced that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration to seek market approval of a lower strength of lubiprostone (8 mcg) to treat irritable bowel syndrome with constipation (IBS-C).

13 Jul 2007

Baxter presents findings from the ADAPT study

Baxter Healthcare Corporation has announced the presentation of findings from the ADAPT (Analysis of Data from ADVATE Prospective Trials) study program database showing a statistically significant relationship between the duration of time spent with factor VIII blood levels below one international unit per deciliter (1 IU/dL, one percent of normal factor VIII level) and an increase in the annual bleed rate in people with hemophilia A.

11 Jul 2007

Incretin-based therapy offers alternative option for treating type 2 diabetes

A review of previous studies indicates that use of a class of medications known as “incretin-based therapy”, which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.

11 Jul 2007

Researchers pinpoint brain region responsible for pain's ability to affect cognitive processing

Anybody who's tried to concentrate on work while suffering a headache knows that pain compellingly commands attention,which is how evolution helped ensure survival in a painful world.

9 Jul 2007

It may be 'altitude sickness' rather than jet lag but you still feel rotten

A study has revealed that many of the effects of long-distance flight which are usually put down to jet lag and fatigue, may in fact be altitude sickness.

5 Jul 2007

Catastrophic head injuries in football dramatically higher at high school level than college level

The incidence of catastrophic head injuries in football is dramatically higher at the high school level than at the college level, according to a study published in the July issue of The American Journal of Sports Medicine.

4 Jul 2007

Meningococcal vaccine now recommended for ages 11 to 18

Recommendations by the Centers for Disease Control and Prevention, (CDC), that all young people aged 11 to 18 should get a shot that protects them from the most dangerous type of meningitis, has been applauded by the National Foundation for Infectious Diseases (NFID).

28 Jun 2007

Latest food scare... sesame seeds with Salmonella

In the latest food scare to hit North America the Canadian Food Inspection Agency (CFIA) is warning the public not to consume certain sesame seeds because they may be contaminated with Salmonella.

21 Jun 2007

New treatments for migraines and chronic headaches

Twelve percent of the population, three quarters of them women, suffer at least occasionally from migraines and about 5 percent from chronic headaches.

20 Jun 2007

Summertime is tick time and Lyme disease is on the rise

The Centers for Disease Control and Prevention (CDC) in the United States says cases of the tick borne illness Lyme disease are on the rise across the country.

18 Jun 2007

Solvay Pharmaceuticals submits supplemental NDA for AndroGel

Solvay Pharmaceuticals, Inc., has announced that it submitted a supplemental New Drug Application (sNDA) for AndroGel (testosterone gel) 1% CIII to the U.S. Food and Drug Administration (FDA) for treatment in male adolescents ages 13-17 years old with primary or secondary hypogonadism.

17 Jun 2007